| IBRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the IBRX shares outstanding history going back to 3/3/2021:
Also see: IBRX Market Cap History IBRX YTD Return |
IBRX Shares Outstanding History — ImmunityBio Share Count Over Time
As of 5/5/2026 ImmunityBio has 1.05 billion IBRX shares outstanding. Investors often track the IBRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows IBRX share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 3/3/2021.
| IBRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
IBRX Historical Shares Outstanding: +54.78% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| IBRX Stock Price Chart |
| About ImmunityBio Inc |
| ImmunityBio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to enhance the immune system against cancers and infectious diseases. It uses proprietary platforms to activate both the innate and adaptive immune systems, targeting cancer and pathogens. These platforms include antibody-cytokine fusion proteins, DNA, RNA, and recombinant protein vaccines, and cell therapies. Its lead product candidate, Anktiva, is an IL-15 superagonist antibody-cytokine fusion protein designed to boost immune response. ImmunityBio aims to orchestrate a comprehensive immune attack on cancer and infectious diseases through its innovative therapies. We show 22 historical shares outstanding datapoints in our coverage of IBRX's shares outstanding history. Understanding the changing numbers of IBRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like IBRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching IBRX by allowing them to research IBRX shares outstanding history as well as any other stock in our coverage universe. |
| IBRX Current Stock Quote |
Quotes delayed 20 minutes  Free IBRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| IBRX Share Performance |
| Shares Outstanding Peers |
| ImmunityBio (IBRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ICAD Shares Outstanding History ICCC Shares Outstanding History ICLR Shares Outstanding History ICPT Shares Outstanding History ICUI Shares Outstanding History ICVX Shares Outstanding History IDRA Shares Outstanding History IDXG Shares Outstanding History IDXX Shares Outstanding History IDYA Shares Outstanding History More Healthcare companies » |
IBRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
